Engineering firm AcroMeta, which focuses on controlled environment projects, has won two contracts worth $6 million.
The company’s clients are mainly from the healthcare, biomedical, pharmaceutical, research and academia sectors.
The first project is a follow-up expansion project from a customer in the biotechnology sector, which comes on top a laboratory built by AcroMeta for the same client back in May 2021.
The second project involves the construction of joint laboratory facility for two companies similarly in the biotechnology space, specialising in advance immunotherapy.
AcroMeta says these contracts will contribute positively to its earnings for the current Sept 30.
AcroMeta shares last traded at 6.9 cents.
See also: Kingsmen renews F1 contracts for $53.2 million
